Overview

A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 (CRPS).
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Elgene Chemical